Supernus (INDV) EBITDA (2024 - 2026)
Indivior Pharmaceuticals (INDV) recorded EBITDA of $181 million in Q3 2026, up 293.5% from $46 million a year earlier and up 11.7% from the prior quarter.
Powered by 
Analysis
Supernus (INDV) EBITDA (2024 - 2026) Analysis & Trends
On a TTM basis, Indivior Pharmaceuticals' EBITDA came in at $565 million as of Sep 30, 2026, up 135.4% year-over-year; for FY2025, it was $272 million, up 403.7% from FY2024.
- Annual EBITDA has a four-year compound annual growth rate of 4.5% (FY2021 to FY2025).
- Across earlier years, EBITDA came in at $54 million in FY2024, -$137 million in FY2023, -$61 million in FY2022 and $228 million in FY2021.
- The Q3 2026 figure is the highest quarterly EBITDA in data going back to Q1 2024.
- On a year-over-year basis, EBITDA has increased for five consecutive quarters, with growth averaging 96.8% over the last six quarters.
- Per Business Quant, the preceding three quarters came in at $162 million (Q2 2026), $139 million (Q1 2026) and $83 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 13.33 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 8.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 8.16 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 7.37 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 4.83 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 4.20 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 7.05 Bn |
| 10 | Supernus | 4.28 Bn | 3.38 Bn | 305.00 Mn | 181.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 181.00 Mn |
| Jun 30, 2026 | 162.00 Mn |
| Mar 31, 2026 | 139.00 Mn |
| Dec 31, 2025 | 83.00 Mn |
| Sep 30, 2025 | 46.00 Mn |
| Jun 30, 2025 | 74.00 Mn |
| Mar 31, 2025 | 69.00 Mn |
| Dec 31, 2024 | 51.00 Mn |
| Sep 30, 2024 | 39.00 Mn |
| Jun 30, 2024 | -116.00 Mn |
| Mar 31, 2024 | 80.00 Mn |
API Access
Supernus EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();